I am excited to share that our three abstracts submitted for the ASHI 51st Annual Meeting have been selected: two for oral presentation and one as a poster! I look forward to discussing Histocompatibility in the HCT setting with the ASHI community! Carmem Bonfim ASHI HLA

🫀This study reports trends in the epidemiology of surgical site infections complicating coronary artery bypass graft surgery and describes changes in surgical antimicrobial prophylaxis compliance and causative pathogens over time #SurgeryUpdates ow.ly/LEco50VRCvc

🚨‼️24 hour warning‼️🚨 Abstract submission for #pccs2025 in Belfast will close tomorrow (30th May) Don’t miss your opportunity to show off your hard work! Click below to submit or book early bird tickets pccsbelfast25.com #pedsicu #giantsteps

Letermovir in Pediatric Allo-HSCT 📍 Italy | n=287 | 2014–2023 CMV Reactivation @ 3 months: ⚠️ No prophylaxis: 29.5% ✅ Primary Letermovir: 3.7% (p=0.0029) ✅ Secondary Letermovir: 0% vs 34.7% (no prophylaxis) ✅ Letermovir = safe, effective 𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM

Excelente presentación Carol Garcia-Vidal Recomendaciones actuales de manejo en Neutropenia Febril 2025 #CarrerasMensa2025 GETH #HematoEnRed @sehh_es SEHH Joven

comparative overview of #voclosporin, #tacrolimus, and #cyclosporine

💊 Not all carbapenem-resistant Pseudomonas aeruginosa strains ... : Current Opinion in Infectious Diseases journals.lww.com/co-infectiousd…

🚨 Ministerio de Sanidad necesitamos un cambio en la normativa de financiación de Letermovir en pacientes CMV+ con Trasplante Alogénico de Progenitores Hematopoyeticos, que reciben #PTCy como profilaxis #EICR (Linfodeplecion T IN VIVO) 🚨 Impacto en OS, complicaciones y costos

Irene García-Cadenas “Otros Herpes Virus en TPH y CART” — Bullet points #CarrerasMensa25 GETH - PTLD en la era #PTCy - Letermovir e incidencia #HHV6 - Integración Cromosómica HHV6 - No monitorizar de rutina en #CART - TODOS Aciclovir profiláctico HSV y VZV #HematoEnRed @sehh_es

Now there are 44 Cell gene therapies approved in the US - Hematology 23 - Oncology 6 - Neurology 5 - Dermatology 3 - Ophthalmology 2 - Others 5 Will we see a surge in the Oncology field based on what we are seeing at #ASCO2025 #ASCO25 #MedTwitter #MedEd OncoAlert USMIRC News

💊Medicine induced crystalline nephropathy AJKD core curriculum

🔥Useful resource: Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group - Clinical Microbiology and Infection clinicalmicrobiologyandinfection.com/article/S1198-…

Please repost: We have a postdoc position in Fungal Cell Wall Research to study the Malassezia-host interaction interface in the context of atopic dermatitis. ⁦MRC Centre for Medical Mycology⁩; ⁦ECMM⁩; ⁦ISHAM⁩ For more details, visit: jobs.exeter.ac.uk/hrpr_webrecrui…

Don't Miss Out - Register Today! Speakers will address the complexities surrounding organ transplant guidelines, and the high-risk populations. For more information, please visit ichs.org/page-1863373

Corticosteroids appear beneficial for many patients with non-viral/bacterial CAP. However, the era of broad indications may be over, and the future probably lies in targeted, biomarker-guided therapy as part of an enrichment strategy in well-designed RCTs. link.springer.com/article/10.100…

Comparable efficacy of venetoclax 50mg with posaconazole versus venetoclax 400mg in newly diagnosed AML patients: pharmacokinetics and clinical outcomes. ascopubs.org/doi/10.1200/JC… #ASCO2025 #POSTER #Thesis-Great full to mentors Gaurav Prakash M.D. Pankaj Malhotra DrArihant@jain

Interesante #EnsayoClinico en Nature Portfolio, 120 pacientes infección #Cdifficile💩donde #PROBIOTICOS (250mg/12h #Saccharomyces #boulardii)➕ #VANCOMICINA presentó MAYOR CURACIÓN (96%🆚85%)👌🏻y MENOS RECIDIVAS (1.7%🆚13%)🔄q Vancomicina 💊+ placebo🍬 🔗🆓nature.com/articles/s4159…

Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline doi.org/10.1007/s15010…

Congratulations to the Newly Elected ISHAM Council Members for the 2025–2028 Term!

We are delighted to celebrate the successful completion of another outstanding Workshop, “Veterinary Mycology in Practice and One Health,” 20th May 2025 at the Bourbon Cataratas Convention Center in Iguaçu Falls, Brazil. vetmyco.com